Results 21 to 30 of about 1,670 (156)
Nefrología, 2023 Resumen: La enfermedad de Fabry o también llamada de Anderson-Fabry (EF) es una enfermedad rara, causada por variantes patogénicas en el gen GLA, localizado en el cromosoma X.
Pablo Rodríguez Doyágüez +5 more
doaj +1 more source
Nefrología (English Edition), 2023 Fabry disease or also called Anderson-Fabry disease (FD) is a rare disease caused by pathogenic variants in the GLA gene, located on the X chromosome.
Pablo Rodríguez Doyágüez +5 more
doaj +1 more source
Corrigendum: Case report: De novo mutation of a-galactosidase A in a female patient with end-stage renal disease: report of a case of late diagnosis of Anderson–Fabry disease [PDF]
Frontiers in GeneticsIrene Simonetta +8 more
doaj +2 more sources
Anderson-Fabry Disease: A Multiorgan Disease [PDF]
Current Pharmaceutical Design, 2013 Fabry disease (FD) is a rare X-linked lysosomal storage disorder caused by a deficiency of the enzyme α-galactosidase A. FD causes glycolipids, such as globotriaosylceramide (Gb3), to accumulate in the vascular endothelium of several organs (Fig. 2), including the skin, kidneys, nervous system, and heart, thereby triggering inflammation and fibrosis ...
Antonino, Tuttolomondo +5 more
openaire +3 more sources
Exosomal miRNAs as Biomarkers of Ischemic Stroke
Brain Sciences, 2023 Exosomes are small lipid bilayer membrane particles released from all living cells into the extracellular environment. They carry several molecules and have a critical role in cell–cell communication under physiological and pathological conditions.
Anna Maria Ciaccio +1 more
doaj +1 more source
Revista Portuguesa de Cardiologia, 2014 Anderson-Fabry disease is an X-linked lysosomal storage disorder caused by abnormalities of the GLA gene, which encodes the enzyme α-galactosidase A. A deficiency of this enzyme leads to the lysosomal accumulation of glycosphingolipids, which may cause ...
Francisca Caetano +4 more
doaj +1 more source
Journal of the American Society of Nephrology, 2002 The advent of enzyme replacement therapy for Anderson-Fabry disease (AFD) adds impetus for the early detection of patients with this inherited multiorgan lipid storage disease. The resultant accumulation of neutral glycosphingolipids, especially globotriaosylceramide (Gb3), in various cell ...
Edwin H, Kolodny, Gregory M, Pastores
openaire +2 more sources
Histopathological findings in renal biopsies in Anderson–Fabry disease. Case series
Revista Médica del Hospital General de México, 2018 Anderson–Fabry disease is the second most common lysosomal storage disease after Gaucher disease. It is an X-linked lysosomal disorder that causes a deficiency in alpha-galactosidase, leading to the accumulation of globotriaosylceramide (Gb3) in the ...
A.L. Mena Rodríguez +3 more
doaj +1 more source
Cardiac Anderson-Fabry disease: Lessons from a 25-year-follow up
Revista Portuguesa de Cardiologia, 2014 Sarcomeric hypertrophic cardiomyopathy (HCM) is the most common genetic cause of unexplained left ventricular hypertrophy and has no specific treatment. Anderson-Fabry disease (AFD) is rare and usually multisystemic, but occasionally expresses clinically
Dulce Brito +4 more
doaj +1 more source
А rare case of alcohol septal ablation and cardioverter-defibrillator implantation in patient with Anderson-Fabry disease [PDF]
Българска кардиологияAnderson-Fabry disease is a hereditary, X-linked disorder with multiorgan impairment. The debut of the disease is usually in childhood, the clinical course and the prognosis are determined by the degree of the heart, kidney and brain ...
M. Dimova +4 more
doaj +3 more sources